Hyperlipidemia and cardiovascular disease: reinforcement for 'lower is better'.
Institute of Laboratory Medicine, Clinical Chemistry and Molecular Diagnostics, University Hospital Leipzig LIFE - Leipzig Research Center for Civilization Diseases, Leipzig University, Leipzig, Germany.
Ralph
R
Burkhardt
D002986:Clinical Trials as Topic; D003324:Coronary Artery Disease / Q000201:enzymology / Q000209:etiology / Q000517:prevention & control*; D006801:Humans; D006937:Hypercholesterolemia / Q000150:complications / Q000188:drug therapy* / Q000201:enzymology; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases / Q000037:antagonists & inhibitors / Q000378:metabolism; D012697:Serine Endopeptidases / Q000378:metabolism; D015842:Serine Proteinase Inhibitors / Q000494:pharmacology / Q000627:therapeutic use
D015842:Serine Proteinase Inhibitors; C472125:PCSK9 protein, human; D000071449:Proprotein Convertase 9; D043484:Proprotein Convertases; D012697:Serine Endopeptidases